A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| Iloprost | Iloprost is a drug used to treat pulmonary arterial hypertension (PAH), scleroderma, Raynaud's phenomenon and other diseases in which the blood vessels are constricted and blood can't flow to the tissues. Alternative Names: Pentanoic acid, 5-[(3aS,4R,5R,6aS)-hexahydro-5-hydroxy-4-[(1E,3S)-3-hydroxy-4-methyl-1-octen-6-yn-1-yl]-2(1H)-pentalenylidene]-, (5E)-; (5E)-5-[(3aS,4R,5R,6aS)-Hexahydro-5-hydroxy-4-[(1E,3S)-3-hydroxy-4-methyl-1-octen-6-yn-1-yl]-2(1H)-pentalenylidene]pentanoic acid; Pentanoic acid, 5-[(3aS,4R,5R,6aS)-hexahydro-5-hydroxy-4-[(1E,3S)-3-hydroxy-4-methyl-1-octen-6-ynyl]-2(1H)-pentalenylidene]-, (5E)-; (1S,2R,3R,5S)-7-[(E)-4-Carboxybutylidene]-2-[(3S,1E)-3-hydroxy-4-methyl-6-octyn-1-enyl]-bicyclo[3.3.0]octane; Ciloprost; Endoprost; Ilomedin; ZK 36374. Grades: 98%. CAS No. 78919-13-8. Molecular formula: C22H32O4. Mole weight: 360.49. |  |
| Iloprost | A synthetic analogue of prostacyclin, it is used as the trometamol salt (generally by intravenous infusion) for the treatment of peripheral vascular disease and pulmonary hypertension. It has a role as a platelet aggregation inhibitor and a vasodilator agent. Category: Active pharmaceutical ingredients. Synonyms: Ciloprost. Ventavis. Endoprost. Ilomedin. CAS No. 78919-13-8. Product ID: API78919138. Molecular formula: C22H32O4. Mole weight: 360.5. EINECS: 636-055-8. SMILES: CC#CCC(C)C(C=CC1C(CC2C1CC(=CCCCC(=O)O)C2)O)O. Appearance: Colourless to Pale Yellow Oil to Solid. |  |
| Iloprost | Iloprost (ZK 36374; Ciloprost) is a prostacyclin (PGI2) analogue, involves in embryo development and inflammation improvement, and inhibits tumor metastasis. Iloprost can be used for peripheral vascular research[1][2][3][4]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: Ciloprost; ZK 36374. CAS No. 78919-13-8. Pack Sizes: 10 mM * 1 mL in DMSO; 2 mg; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-A0096. |  |
| Iloprost-[d4] (Major) | Iloprost-[d4] is a labelled analogue of Iloprost. A labelled synthetic analogue of Prostacyclin (PGI2) used to treat pulmonary arterial hypertension (PAH), scleroderma, Raynaud's phenomenon and ischemia. It acts through elevation of cAMP by binding to the prostacyclin receptor (IP receptor). Iloprost inhibits the ADP, thrombin. In whole animals, iloprost acts as a vasodilator, hypotensive, antidiuretic, and prolongs bleeding time. Alternative Names: (5E)-5-[(3aS,4R,5R,6aS)-Hexahydro-5-hydroxy-4-[(1E,3S)-3-hydroxy-4-methyl-1-octen-6-yn-1-yl]-2(1H)-pentalenylidene]pentanoic Acid-d4; (1S,2R,3R,5S)-7-[(E)-4-Carboxybutylidene]-2-[(3S,1E)-3-hydroxy-4-methyl-6-octyn-1-enyl]-bicyclo[3.3.0]octane-d4; Ciloprost-d4; Endoprost-d4. Grades: 98% by CP; 98% atom D. CAS No. 1035094-10-0. Molecular formula: C22H28D4O4. Mole weight: 364.51. | |
| Ilorasertib hydrochloride | Ilorasertib (ABT-348) hydrochloride is a potent, orally active and ATP-competitive aurora inhibitor with IC50s of116, 5, 1 nM for aurora A, aurora B, aurora C, respectively. Ilorasertib hydrochloride also is a potent VEGF, PDGF inhibitor. Ilorasertib hydrochloride has the potential for the research of acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS)[1][2]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: ABT-348 hydrochloride. CAS No. 1847485-91-9. Pack Sizes: 10 mM * 1 mL in DMSO; 1 mg; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-16018A. | |
| ILP | ILP is an analog of insulin, a pancreatic hormone that regulates glucose metabolism, cellular uptake, as well as the storage of glucose, amino acids and fatty acids. Alternative Names: Insulin-like peptide; Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-Cys-Asp-Leu-Ala-Asp-Asn-Ile-Glu-Arg-Leu-Lys-Ala-Asn-Asp-Gly-Leu-Lys-Phe-Ser-Gln-Glu-Tyr-Glu-Ser-Ile-NH2. Molecular formula: C178H303N65O54S. Mole weight: 4250.00. | |
| ILS-920 | ILS-920 is a nonimmunosuppressive Rapamycin analog with reduced immunosuppressive activity and potent neuroprotective activity. ILS-920 binds selectively to the immunophilin FKBP52 and to the β1-subunit of L-type voltage-gated calcium channels (VGCC). ILS-920 shows 200-fold selectivity for FKBP52 versus FKBP12[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 892494-07-4. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg. Product ID: HY-106345. | |
| Ilunocitinib | Ilunocitinib (compound 27) is a JAK inhibitor (extracted from patent WO2009114512A1)[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: LY-3411067. CAS No. 1187594-14-4. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-132819. | |
| Ilunocitinib | Ilunocitinib is a Janus kinase (JAK) inhibitor (veterinary use). Alternative Names: {1-(cyclopropanesulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]azetidin-3-yl}acetonitrile; 2-(3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-1-(cyclopropylsulfonyl)azetidin-3-yl)acetonitrile; 3-Azetidineacetonitrile, 1-(cyclopropylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]-. CAS No. 1187594-14-4. Molecular formula: C17H17N7O2S. Mole weight: 383.43. | |
| Ilutinib impurity 10 | Ilutinib impurity 10. Uses: For analytical and research use. CAS No. 1022150-11-3. Molecular formula: C27H30N6O3. Mole weight: 486.58. Catalog: APB1022150113. |  |
| Ilutinib impurity 11 | Ilutinib impurity 11. Uses: For analytical and research use. CAS No. 1642630-12-3. Molecular formula: C22H22N6O. Mole weight: 386.46. Catalog: APB1642630123. | |
| Ilutinib impurity 12 | Ilutinib impurity 12. Uses: For analytical and research use. CAS No. 2213398-75-3. Molecular formula: C18H15N5O. Mole weight: 317.35. Catalog: APB2213398753. | |
| Ilutinib impurity 13 | Ilutinib impurity 13. Uses: For analytical and research use. CAS No. 1899859-31-4. Molecular formula: C20H25NO5. Mole weight: 359.42. Catalog: APB1899859314. | |
| Ilutinib impurity 14 | Ilutinib impurity 14. Uses: For analytical and research use. CAS No. 2244619-11-0. Molecular formula: C28H28N6O4. Mole weight: 512.57. Catalog: APB2244619110. | |
| Ilutinib impurity 15 | Ilutinib impurity 15. Uses: For analytical and research use. Molecular formula: C50H48N12O4. Mole weight: 881.01. Catalog: APB11051. | |
| Ilutinib impurity 16 | Ilutinib impurity 16. Uses: For analytical and research use. Molecular formula: C50H48N12O4. Mole weight: 881.01. Catalog: APB11050. | |
| Ilutinib impurity 17 | Ilutinib impurity 17. Uses: For analytical and research use. CAS No. 2417548-83-3. Molecular formula: C50H48N12O4. Mole weight: 881.01. Catalog: APB2417548833. | |
| Ilutinib impurity 18 | Ilutinib impurity 18. Uses: For analytical and research use. Molecular formula: C50H48N12O4. Mole weight: 881.01. Catalog: APB11052. | |
| Ilutinib impurity 19 | Ilutinib impurity 19. Uses: For analytical and research use. Molecular formula: C23H24N6O3S. Mole weight: 464.54. Catalog: APB11053. | |
| Ilutinib impurity 3 | Ilutinib impurity 3. Uses: For analytical and research use. CAS No. 1839099-22-7. Molecular formula: C25H26N6O2. Mole weight: 442.52. Catalog: APB1839099227. | |
| Ilutinib impurity 4 | Ilutinib impurity 4. Uses: For analytical and research use. Molecular formula: C50H50N12O4. Mole weight: 883.03. Catalog: APB11044. | |
| Ilutinib impurity 5 | Ilutinib impurity 5. Uses: For analytical and research use. Molecular formula: C25H26N6O3. Mole weight: 458.52. Catalog: APB11045. | |
| Ilutinib impurity 6 | Ilutinib impurity 6. Uses: For analytical and research use. Molecular formula: C28H28N6O4. Mole weight: 512.57. Catalog: APB11046. | |
| Ilutinib impurity 7 | Ilutinib impurity 7. Uses: For analytical and research use. Molecular formula: C37H47N7O5. Mole weight: 669.83. Catalog: APB11047. | |
| Ilutinib impurity 8 | Ilutinib impurity 8. Uses: For analytical and research use. Molecular formula: C33H24N8O3. Mole weight: 580.61. Catalog: APB11048. | |
| Ilutinib impurity 9 | Ilutinib impurity 9. Uses: For analytical and research use. Molecular formula: C32H22N8O2. Mole weight: 550.58. Catalog: APB11049. | |
| Iluzanebart | Iluzanebart is a human monoclonal IgG1 antibody and is the agonist antibody for human TREM2 (hTREM2). Iluzanebart improves the survival and function of microglia by activating the TREM2 signaling pathway to compensate for the loss of CSF1R function. Iluzanebart can be used for research of adult-onset leukoencephalopathy associated with CSF1R (colony stimulating factor 1 receptor) (CSF1R-ALSP)[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: VGL101. CAS No. 2733621-19-5. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P990043. | |
| Im-1 | Im-1 is an antibacterial peptide isolated from Isometrus maculatus (Lesser brown scorpion). It has activity against gram-positive bacteria, gram-negative bacteria and Parasites. Alternative Names: Phe-Ser-Phe-Lys-Arg-Leu-Lys-Gly-Phe-Ala-Lys-Lys-Leu-Trp-Asn-Ser-Lys-Leu-Ala-Arg-Lys-Ile-Arg-Thr-Lys-Gly-Leu-Lys-Tyr-Val-Lys-Asn-Phe-Ala-Lys-Asp-Met-Leu-Ser-Glu-Gly-Glu-Glu-Ala-Pro-Pro-Ala-Ala-Glu-Pro-Pro-Val-Glu-Ala-Pro-Gln. Molecular formula: C292H467N79O77S. Mole weight: 6348.46. | |
| IM-12 | IM-12 is an inhibitor of GSK-3β, with an IC50 of 53 nM, and also enhances Wnt signalling. Uses: Scientific research. Category: Signaling pathways. CAS No. 1129669-05-1. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-12292. | |
| IM-54 | IM-54 is a selective inhibitor of oxidative stress-induced necrosis. IM-54 shows potent inhibitory activity against H2O2-induced necrosis. IM-54 acts as a potential cardioprotective agent and biological tool for investigating the molecular mechanisms of cell death[1][2]. Uses: Scientific research. Category: Signaling pathways. CAS No. 861891-50-1. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-108351. | |
| IMAB027 | IMAB027 (ASP1650) is a specific anti-CLDN6 mAb, while CLDN6 (Claudin 6) is a tight junction membrane protein, aberrantly expressed in various human cancer types, ovarian cancers particularly. IMAB 027 shows anti-tumor activity, and induces apoptosis in CLDN6+ ovarian and testicular cancer cell lines[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: ASP1650. CAS No. 1650599-68-0. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99413. | |
| iMAC2 | iMAC2. Group: Biochemicals. Grades: Purified. CAS No. 335166-00-2. Pack Sizes: 10mg, 50mg. US Biological Life Sciences. |  Worldwide |
| iMAC2 hydrochloride | iMAC2 hydrochloride is a potent MAC (mitochondrial apoptosis-induced channel) inhibitor, with an IC50 of 28 nM and a LD50 of 15000 nM. iMAC2 hydrochloride shows anti-apoptotic effect. iMAC2 hydrochloride blocks cytochrome c release[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 335166-00-2. Pack Sizes: 1 mg; 5 mg. Product ID: HY-110073. | |
| Imalumab | Imalumab (BAX69) is a recombinant, human IgG1 monoclonal antibody that targets macrophage inhibitory factor (MIF). Imalumab can be used for the research of ovarian carcinoma, recurrent malignant ascites and cancer[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: BAX69; Anti-Human MIF Recombinant Antibody. CAS No. 1430205-07-4. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99262. | |
| Imaradenant | AZD4635 (HTL1071) is a potent, selective and orally active adenosine A2A receptor (A2AR) antagonist. AZD4635 binds to human A2AR with a Ki of 1.7 nM and shows >30-fold selectivity over other adenosine receptors[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: HTL1071; AZD4635. CAS No. 1321514-06-0. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-101980. | |
| Imatinib | Imatinib (STI571) is an orally bioavailable tyrosine kinases inhibitor that selectively inhibits BCR/ABL, v-Abl, PDGFR and c-kit kinase activity. Imatinib (STI571) works by binding close to the ATP binding site, locking it in a closed or self-inhibited conformation, therefore inhibiting the enzyme activity of the protein semicompetitively[1][2][3][4]. Imatinib also is an inhibitor of SARS-CoV and MERS-CoV[5]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: STI571; CGP-57148B. CAS No. 152459-95-5. Pack Sizes: 10 mM * 1 mL in DMSO; 200 mg; 500 mg; 1 g; 5 g; 10 g. Product ID: HY-15463. | |
| Imatinib | Imatinib inhibits the SLF-dependent activation of wild-type c-kit kinase activity with an IC50 for these effects of approximately 0.1 μM, which is similar to the concentration required for inhibition of PDGFR. Imatinib is an oral chemotherapy agent used to treat cancers. Specifically, it is used for chronic myelogenous leukemia (CML) and acute lymphocytic leukemia (ALL) that are Philadelphia chromosome-positive (Ph+), certain types of gastrointestinal stromal tumors (GIST), hypereosinophilic syndrome (HES), chronic eosinophilic leukemia (CEL), systemic mastocytosis, and myelodysplastic syndrome. Alternative Names: CGP057148B; STI571; Gleevec; Glivec; N-(4-Methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide; 4-[(4-Methyl-1-piperazinyl)methyl]-N-(4-methyl-3-{[4-(3-pyridinyl)-2-pyrimidinyl]amino}phenyl)benzamide. Grades: >98%. CAS No. 152459-95-5. Molecular formula: C29H31N7O. Mole weight: 493.60. | |
| Imatinib-d4 | Imatinib-d4 (STI571-d4) is a deuterium labeled Imatinib (STI571). Imatinib is an orally bioavailable tyrosine kinases inhibitor that selectively inhibits BCR/ABL, v-Abl, PDGFR and c-kit kinase activity[1][2]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: STI571 d4; CGP-57148B d4. CAS No. 1134803-16-9. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-15463S1. | |
| Imatinib-[d4] | Imatinib-[d4] is an isotopically labelled analogue of Imatinib. Imatinib is an inhibitor of multiple tyrosine kinases. It is a COVID-19-related research product. Alternative Names: N-(4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide-2,3,5,6-d4; Imatinib D4. Grades: ≥98% (HPLC). CAS No. 1134803-16-9. Molecular formula: C29H27D4N7O. Mole weight: 497.64. | |
| Imatinib-d8 | Imatinib-d8 is a deuterium labeled Imatinib (STI571). Imatinib is an orally bioavailable tyrosine kinases inhibitor that selectively inhibits BCR/ABL, v-Abl, PDGFR and c-kit kinase activity[1][2]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: STI571-d8; CGP-57148B-d8. CAS No. 1092942-82-9. Pack Sizes: 10 mM * 1 mL in DMSO; 1 mg; 5 mg; 10 mg. Product ID: HY-15463S. | |
| Imatinib-d8 | Imatinib-d8 is a deuterated tyrosine kinase inhibitor. Group: Biochemicals. Grades: Highly Purified. CAS No. 1092942-82-9. Pack Sizes: 1mg, 10mg. Molecular Formula: C29H23D8N7O. US Biological Life Sciences. | Worldwide |
| Imatinib-d8 Methanesulfonate (STI-571-d8, CGP-57148B-d8) | A deuterated tyrosine kinase inhibitor. Highly specific for BCR-ABL, the enzyme associated with chronic myelogenous leukemia (CML) and certain forms of acute lymphoblastic leukemia (ALL). Group: Biochemicals. Alternative Names: Imatinib-d8 Methanesulfonate, STI-571-d8, CGP-57148B-d8, Glivec-d8. Grades: Highly Purified. Pack Sizes: 500ug. US Biological Life Sciences. | Worldwide |
| Imatinib Dimer Impurity | Imatinib Dimer Impurity. Uses: For analytical and research use. CAS No. 1365802-18-1. Molecular formula: C52H48N12O2. Mole weight: 873.04. Catalog: APB1365802181. | |
| Imatinib EP Impurity B | Imatinib EP Impurity B. CAS No. 581076-65-5. | |
| Imatinib EP Impurity B HCl | Imatinib EP Impurity B HCl. Uses: For analytical and research use. CAS No. 581076-67-7. Molecular formula: C21H29ClN6O. Mole weight: 416.95. Catalog: APB581076677. | |
| Imatinib EP Impurity C-D8 | Imatinib EP Impurity C-D8. Uses: For analytical and research use. CAS No. 1185103-28-9. Molecular formula: C28H21D8N7O. Mole weight: 487.64. Catalog: APB1185103289. | |
| Imatinib EP Impurity D | An impurity of Imatinib, a tyrosine kinase inhibitor used as a chemotherapy drug for the treatment of leukemia and other kinds of cancer. Alternative Names: Des(methylpiperazinyl) Imatinib Dimer Piperazinium Chloride; 1-Methyl-1,4-bis[4-[(4-methyl-3-[[4-(pyridin-3-yl)pyrimidin-2-yl]amino]phenyl)carbamoyl]benzyl]piperazin-1-ium chloride. Grades: > 95%. CAS No. 1821122-73-9. Molecular formula: C53H51ClN12O2. Mole weight: 923.50. | |
| Imatinib EP Impurity D | Imatinib EP Impurity D. Uses: For analytical and research use. CAS No. 1821122-73-9. Molecular formula: C53H51N12O2. Mole weight: 888.07. Catalog: APB1821122739. | |
| Imatinib EP Impurity H | Imatinib EP Impurity H. Uses: For analytical and research use. CAS No. 350-03-8. Molecular formula: C7H7NO. Mole weight: 121.14. Catalog: APB350038. | |
| Imatinib EP Impurity J | An impurity of Imatinib, a tyrosine kinase receptor inhibitor used for cancer therapy. Alternative Names: Imatinib (Piperidine)-N-oxide; 4-[(4-Methyl-4-oxido-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide; CGP 71422; CGP71422; CGP-71422. Grades: > 95%. CAS No. 571186-91-9. Molecular formula: C29H31N7O2. Mole weight: 509.62. | |
| Imatinib, Free base | An inhibitor of the bcr-abl tyrosine kinase. It acts by binding to the ATP binding site of bcr-abl. Imatinib also stimulates the entry of the bcr-abl tyrosine kinase into the nucleus, where it cannot perform its anti-apoptopic functions. It inhibits EOL-1 cell viability (IC50=0.5nm), phosphorylation of a fusion protein (IC50=30nm), and viability of BaF3 cells expressing Rhe-PDGFRa in the absence of IL-3 (IC50 =0.17nm). Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 100ug, 1g. US Biological Life Sciences. | Worldwide |
| Imatinib Imidazole Impurity | Imatinib Imidazole Impurity. Uses: For analytical and research use. CAS No. 1256080-10-0. Molecular formula: C32H31N9O2. Mole weight: 573.66. Catalog: APB1256080100. | |
| Imatinib Impurity 11 | Imatinib Impurity 11. Uses: For analytical and research use. CAS No. 796738-71-1. Molecular formula: C16H13N5O2. Mole weight: 307.31. Catalog: APB796738711. | |
| Imatinib Impurity 12 | Imatinib Impurity 12. Uses: For analytical and research use. CAS No. 112696-91-0. Molecular formula: C16H15N5. Mole weight: 277.33. Catalog: APB112696910. | |
| Imatinib Impurity 16 | Imatinib Impurity 16. Uses: For analytical and research use. CAS No. 152460-09-8. Molecular formula: C16H13N5O2. Mole weight: 307.31. Catalog: APB152460098. | |
| Imatinib Impurity 17 | Imatinib Impurity 17. Uses: For analytical and research use. CAS No. 1802325-93-4. Molecular formula: C20H22N2O4. Mole weight: 354.41. Catalog: APB1802325934. | |
| Imatinib Impurity 18 | Imatinib Impurity 18. Uses: For analytical and research use. CAS No. 404844-11-7. Molecular formula: C24H20ClN5O. Mole weight: 429.91. Catalog: APB404844117. | |
| Imatinib Impurity 2 | Imatinib Impurity 2. Uses: For analytical and research use. CAS No. 1384131-91-2. Molecular formula: C7H11NO. Mole weight: 125.17. Catalog: APB1384131912. | |
| Imatinib Impurity 26 | Imatinib Impurity 26. Uses: For analytical and research use. CAS No. 74231-65-5. Molecular formula: C8H5Cl2N. Mole weight: 186.04. Catalog: APB74231655. | |
| Imatinib Impurity 27 | Imatinib Impurity 27. Uses: For analytical and research use. CAS No. 67013-55-2. Molecular formula: C8H5Br2N. Mole weight: 274.94. Catalog: APB67013552. | |
| Imatinib Impurity 29 | Imatinib Impurity 29. Uses: For analytical and research use. CAS No. 21900-30-1. Molecular formula: C8H6Cl2O. Mole weight: 189.04. Catalog: APB21900301. | |
| Imatinib Impurity 3 | Imatinib Impurity 3. Uses: For analytical and research use. CAS No. 152459-96-6. Molecular formula: C24H21N5O. Mole weight: 395.47. Catalog: APB152459966. | |
| Imatinib Impurity 30 | Imatinib Impurity 30. Uses: For analytical and research use. CAS No. 36747-64-5. Molecular formula: C8H5Cl3O. Mole weight: 223.48. Catalog: APB36747645. | |
| Imatinib Impurity 31 | Imatinib Impurity 31. Uses: For analytical and research use. CAS No. 1356565-47-3. Molecular formula: C17H17N7. Mole weight: 319.37. Catalog: APB1356565473. | |
| Imatinib Impurity 32 | Imatinib Impurity 32. Uses: For analytical and research use. CAS No. 16156-50-6. Molecular formula: C7H16O3S. Mole weight: 180.26. Catalog: APB16156506. | |
| Imatinib impurity 35 (Hydrochloride) | Imatinib impurity 35 (Hydrochloride). Uses: For analytical and research use. Alternative Names: 4-((4-methylpiperazin-1-yl)methyl)benzoic acid hydrochloride. Molecular formula: C13H18N2O2·HCl. Mole weight: 361.31. Catalog: APB01554. | |
| Imatinib impurity 36 | Imatinib impurity 36. Uses: For analytical and research use. Alternative Names: 1-methyl-4-(4-((4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)carbamoyl)benzyl)piperazine 1,4-dioxide. CAS No. 571186-93-1. Molecular formula: C29H31N7O3. Mole weight: 525.6. Catalog: APB571186931. | |
| Imatinib Impurity 36 | Imatinib Impurity 36. Uses: For analytical and research use. CAS No. 106261-48-7. Molecular formula: C13H18N2O2. Mole weight: 234.3. Catalog: APB106261487. | |
| Imatinib Impurity 37 | Imatinib Impurity 37. Uses: For analytical and research use. CAS No. 1912-32-9. Molecular formula: C5H12O3S. Mole weight: 152.21. Catalog: APB1912329. | |
| Imatinib Impurity 38 | Imatinib Impurity 38. Uses: For analytical and research use. CAS No. 5973-83-1. Molecular formula: C7H8N2O. Mole weight: 136.15. Catalog: APB5973831. | |
Our database is helping our users find suppliers everyday.
